DK551487D0 - 1-HYDROXYALKYLXANTHINES AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS - Google Patents

1-HYDROXYALKYLXANTHINES AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS

Info

Publication number
DK551487D0
DK551487D0 DK551487A DK551487A DK551487D0 DK 551487 D0 DK551487 D0 DK 551487D0 DK 551487 A DK551487 A DK 551487A DK 551487 A DK551487 A DK 551487A DK 551487 D0 DK551487 D0 DK 551487D0
Authority
DK
Denmark
Prior art keywords
hydroxyalkylxanthines
compounds
pharmaceutical preparations
preparations containing
compound
Prior art date
Application number
DK551487A
Other languages
Danish (da)
Other versions
DK169336B1 (en
DK551487A (en
Inventor
Rene Fumeaux
Georges Philippossian
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of DK551487D0 publication Critical patent/DK551487D0/en
Publication of DK551487A publication Critical patent/DK551487A/en
Application granted granted Critical
Publication of DK169336B1 publication Critical patent/DK169336B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Compound of formula: <IMAGE> or a physiologically acceptable salt of this compound, in which formula R1 is a C2-C5 omega -hydroxy-n-alkyl or C3-C5 ( omega -1)-hydroxy-n-alkyl, R3 is a C1-C4 alkyl group, R8 is H, methyl or ethyl, and the sum of the carbon atoms in R1 and R3 is between 4 and 9. Pharmaceutical composition containing this compound.
DK551487A 1986-10-27 1987-10-21 1-Hydroxyalkylxanthines, Methods of Preparation and Pharmaceutical Preparations Containing Such Compounds DK169336B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH425386 1986-10-27
CH4253/86A CH670090A5 (en) 1986-10-27 1986-10-27

Publications (3)

Publication Number Publication Date
DK551487D0 true DK551487D0 (en) 1987-10-21
DK551487A DK551487A (en) 1988-04-28
DK169336B1 DK169336B1 (en) 1994-10-10

Family

ID=4272668

Family Applications (1)

Application Number Title Priority Date Filing Date
DK551487A DK169336B1 (en) 1986-10-27 1987-10-21 1-Hydroxyalkylxanthines, Methods of Preparation and Pharmaceutical Preparations Containing Such Compounds

Country Status (13)

Country Link
EP (1) EP0269841B1 (en)
JP (1) JP2527769B2 (en)
KR (1) KR930010559B1 (en)
AT (1) ATE82289T1 (en)
AU (1) AU604767B2 (en)
CA (1) CA1296001C (en)
CH (1) CH670090A5 (en)
DE (1) DE3782619T2 (en)
DK (1) DK169336B1 (en)
ES (1) ES2043631T3 (en)
GR (1) GR3006223T3 (en)
IL (1) IL84266A (en)
ZA (1) ZA877851B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0570831A2 (en) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Use of Xanthinderivatives for treatment of cerebral nerve dammages after disruption of the blood circulation
DE4316576A1 (en) * 1993-05-18 1994-11-24 Boehringer Ingelheim Kg Improved process for the preparation of 1,3-dipropyl-8- (3-oxocyclopentyl) xanthine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2517410A (en) * 1947-08-15 1950-08-01 Searle & Co Hydroxy alkyl xanthines and the production thereof
FR1211333A (en) * 1955-10-19 1960-03-15 Boehringer Sohn Ingelheim Improvements in processes for manufacturing oxyalkylxanthines
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same

Also Published As

Publication number Publication date
DK169336B1 (en) 1994-10-10
AU7998087A (en) 1988-04-28
ES2043631T3 (en) 1994-01-01
AU604767B2 (en) 1991-01-03
CA1296001C (en) 1992-02-18
JP2527769B2 (en) 1996-08-28
CH670090A5 (en) 1989-05-12
EP0269841B1 (en) 1992-11-11
JPS63122683A (en) 1988-05-26
DE3782619T2 (en) 1993-04-22
EP0269841A1 (en) 1988-06-08
KR880005131A (en) 1988-06-28
ZA877851B (en) 1988-04-22
DK551487A (en) 1988-04-28
IL84266A0 (en) 1988-03-31
GR3006223T3 (en) 1993-06-21
DE3782619D1 (en) 1992-12-17
KR930010559B1 (en) 1993-10-28
ATE82289T1 (en) 1992-11-15
IL84266A (en) 1992-02-16

Similar Documents

Publication Publication Date Title
DE3372707D1 (en) Spiro-(4,(3+n))-2-aza-alkan-3-carboxylic-acid derivatives, process for their preparation,agents containing them and their use
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
JPS5513278A (en) Benzomorphane compound and medical compound containing it
FI880494A (en) NYA 5-ALCOXY-2,4-DIAMINOALKYLBENZENER SAMT DESSA INNEHAOLLANDE HAORFAERGNINGSMEDEL.
NO800447L (en) DERIVATIVES OF DIFENYL HYDANTOIN, PHARMACEUTICAL PREPARATIONS CONTAINING SUCH PREPARATIONS, AND PROCEDURES FOR THE PREPARATION OF THE ACTIVE COMPOUNDS
MX9300433A (en) PIRIDINCARBOXIMIDAMINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
PH24309A (en) Cycloalkylamides of(8beta)-1-alkyl-6-(substituted)-ergolines and pharmaceutical formulations thereof
DK373783A (en) THIENO-THIAZOL DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE
DK551487D0 (en) 1-HYDROXYALKYLXANTHINES AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS
DE3665593D1 (en) Peptide immunostimulants
GR3001784T3 (en) Amino compounds and fungicides containing them
IL74150A0 (en) Oximinophosphoric acid derivatives,their preparation and their use as pesticides
GR78773B (en)
DE3660546D1 (en) Phosphoroimidates
DE3885978D1 (en) Cephem compounds and processes for their preparation.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
B1 Patent granted (law 1993)
PBP Patent lapsed